Compare Aurobindo Pharma with Torrent Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AUROBINDO PHARMA vs TORRENT PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AUROBINDO PHARMA TORRENT PHARMA AUROBINDO PHARMA/
TORRENT PHARMA
 
P/E (TTM) x 7.4 40.6 18.1% View Chart
P/BV x 1.8 8.8 20.0% View Chart
Dividend Yield % 0.6 1.2 52.7%  

Financials

 AUROBINDO PHARMA   TORRENT PHARMA
EQUITY SHARE DATA
    AUROBINDO PHARMA
Mar-21
TORRENT PHARMA
Mar-21
AUROBINDO PHARMA/
TORRENT PHARMA
5-Yr Chart
Click to enlarge
High Rs1,0233,040 33.7%   
Low Rs3331,933 17.2%   
Sales per share (Unadj.) Rs422.8473.0 89.4%  
Earnings per share (Unadj.) Rs92.074.0 124.3%  
Cash flow per share (Unadj.) Rs110.0112.9 97.5%  
Dividends per share (Unadj.) Rs4.0035.00 11.4%  
Avg Dividend yield %0.61.4 41.9%  
Book value per share (Unadj.) Rs374.3344.9 108.5%  
Shares outstanding (eoy) m585.94169.22 346.3%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x1.65.3 30.5%   
Avg P/E ratio x7.433.6 21.9%  
P/CF ratio (eoy) x6.222.0 28.0%  
Price / Book Value ratio x1.87.2 25.1%  
Dividend payout %4.347.3 9.2%   
Avg Mkt Cap Rs m397,398420,798 94.4%   
No. of employees `000NANA-   
Total wages/salary Rs m35,35014,396 245.6%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m247,74680,048 309.5%  
Other income Rs m3,809757 502.9%   
Total revenues Rs m251,55580,806 311.3%   
Gross profit Rs m81,48024,666 330.3%  
Depreciation Rs m10,5546,578 160.4%   
Interest Rs m7453,583 20.8%   
Profit before tax Rs m73,99015,263 484.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m20,0982,744 732.5%   
Profit after tax Rs m53,89212,519 430.5%  
Gross profit margin %32.930.8 106.7%  
Effective tax rate %27.218.0 151.1%   
Net profit margin %21.815.6 139.1%  
BALANCE SHEET DATA
Current assets Rs m198,23555,232 358.9%   
Current liabilities Rs m106,65248,916 218.0%   
Net working cap to sales %37.07.9 468.5%  
Current ratio x1.91.1 164.6%  
Inventory Days Days1914 133.7%  
Debtors Days Days527 743.0%  
Net fixed assets Rs m135,77881,298 167.0%   
Share capital Rs m586846 69.2%   
"Free" reserves Rs m218,71357,526 380.2%   
Net worth Rs m219,29958,372 375.7%   
Long term debt Rs m1,68429,633 5.7%   
Total assets Rs m334,013136,530 244.6%  
Interest coverage x100.35.3 1,907.4%   
Debt to equity ratio x00.5 1.5%  
Sales to assets ratio x0.70.6 126.5%   
Return on assets %16.411.8 138.7%  
Return on equity %24.621.4 114.6%  
Return on capital %33.821.4 157.9%  
Exports to sales %53.80-   
Imports to sales %16.40-   
Exports (fob) Rs m133,248NA-   
Imports (cif) Rs m40,615NA-   
Fx inflow Rs m133,24821,539 618.6%   
Fx outflow Rs m44,9467,136 629.8%   
Net fx Rs m88,30214,403 613.1%   
CASH FLOW
From Operations Rs m33,28920,107 165.6%  
From Investments Rs m5,987-4,494 -133.2%  
From Financial Activity Rs m-13,648-16,561 82.4%  
Net Cashflow Rs m25,831-893 -2,893.9%  

Share Holding

Indian Promoters % 48.8 71.3 68.4%  
Foreign collaborators % 3.1 0.0 -  
Indian inst/Mut Fund % 37.2 20.3 183.9%  
FIIs % 21.7 11.5 188.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.2 28.8 167.5%  
Shareholders   329,940 64,309 513.1%  
Pledged promoter(s) holding % 24.4 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AUROBINDO PHARMA With:   SOLARA ACTIVE PHARMA SCIENCES  RPG LIFE SCIENCES  LACTOSE INDIA  VISTA PHARMA  DR. REDDYS LAB  



Today's Market

Sensex Falls 1,100 Points from Day's High to End Marginally Lower; Metal & Energy Stocks Witness Selling(Closing)

It was indeed a volatile trading session for Indian share markets today. Benchmark indices reversed course in intraday deals as global cues turned bearish.

Related Views on News

AUROBINDO PHARMA Announces Quarterly Results (1QFY22); Net Profit Down 2.0% (Quarterly Result Update)

Aug 16, 2021 | Updated on Aug 16, 2021

For the quarter ended June 2021, AUROBINDO PHARMA has posted a net profit of Rs 8 bn (down 2.0% YoY). Sales on the other hand came in at Rs 57 bn (down 3.8% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

AUROBINDO PHARMA 2020-21 Annual Report Analysis (Annual Result Update)

Aug 9, 2021 | Updated on Aug 9, 2021

Here's an analysis of the annual report of AUROBINDO PHARMA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of AUROBINDO PHARMA. Also includes updates on the valuation of AUROBINDO PHARMA.

Torrent Pharma Beats Expectations: Stock Gets a Boost (Views On News)

May 19, 2021

Key takeaways from Torrent Pharma's March quarter results.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

More Views on News

Most Popular

Infosys vs TCS: Which is Better?(Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake(Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

Don't Sell these Stocks if the Market Falls(Profit Hunter)

Nov 17, 2021

These are the 3 types of stocks that you should not sell in a market crash.

How to Find Your Next 10-Bagger in this Market(Profit Hunter)

Nov 19, 2021

The #1 make or break factor in your portfolio you shouldn't ignore.

6 Popular Stocks that Turned into Penny Stocks(Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

AUROBINDO PHARMA SHARE PRICE


Nov 30, 2021 (Close)

TRACK AUROBINDO PHARMA

  • Track your investment in AUROBINDO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON AUROBINDO PHARMA

AUROBINDO PHARMA 5-YR ANALYSIS

COMPARE AUROBINDO PHARMA WITH

MARKET STATS